|
|
|
|
|
Teisinis statusas
Patentas panaikintas (nesumokėtas metų mokestis)
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 403/14 | (2006.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61K 31/4025 | (2006.01) | ||
| A61K 31/4178 | (2006.01) |
| (11) | Patento numeris | 2049522 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07800058.5 |
| Europos patento paraiškos padavimo data | 2007-08-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-04-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-05-14 |
| (46) | Apibrėžties vertimo paskelbimo data | 2014-08-25 |
| (86) | Numeris | PCT/US2007/075544 |
| Data | 2007-08-09 |
| (87) | Numeris | WO 2008/021927 |
| Data | 2008-02-21 |
| (30) | Numeris | Data | Šalis |
| 836996 P | 2006-08-11 | US | |
| 835462 | 2007-08-08 | US |
| (72) |
BACHAND, Carol, CA
BELEMA, Makonen, US
DEON, Daniel H., CA
GOOD, Andrew C., US
GOODRICH, Jason, US
JAMES, Clint A., CA
LAVOIE,Rico, US
LOPEZ, Omar D., US
MARTEL, Alain, CA
MEANWELL, Nicholas A., US
NGUYEN, Van N., US
ROMINE, Jeffrey Lee, US
RUEDIGER, Edward H., CA
SNYDER, Lawrence B., US
ST. LAURENT, Denis R., US
YANG, Fukang, US
LANGLEY, David R., US
WANG, Gan, US
HAMANN, Lawrence G., US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland Unlimited Company,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Hepatito C viruso inhibitoriai |
| HEPATITIS C VIRUS INHIBITORS |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2019-07-23 | 13 | 289.00 EUR |
| Patentas panaikintas (nesumokėtas metų mokestis) | ||
| Patento panaikinimo data | 2020-08-09 |